Takashi Kei Kishimoto is CSO at SELECTA BIOSCIENCES INC (SELB). They have made 5 open-market trades across 1 company since 2016, most recently 2023-05-31.
CIK 0001676930
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SELB | 321,316 | $283K |
Shares reported on the most recent Form 4, priced at the 2023-06-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SELB | SELL | 2023-01-04 | 2023-01-06 | $1.13 | $11K | +20.7% | +35.6% | -3.0% |
| SELB | SELL | 2022-01-05 | 2022-01-07 | $3.09 | $11K | -14.4% | -21.9% | -54.1% |
| SELB | SELL | 2021-12-10 | 2021-12-14 | $2.99 | $13K | +11.0% | -10.6% | -52.6% |
| SELB | SELL | 2021-10-13 | 2021-10-15 | $4.39 | $17K | -13.8% | -14.0% | -33.7% |
| SELB | SELL | 2016-12-28 | 2016-12-30 | $17.55 | $176K | -11.7% | -17.3% | -15.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.